EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Efficacy of the Nefertiti Lift for Jawline Contour: A Split‐Face Study

Lucy Xuan Liu, Srivatsa Surya Vasudevan, Alison Hawkins, David Rengifo, Rodrigo Martinez Monedero

The Laryngoscope · 2026-11-02

DOI: 10.1002/lary.71033 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Objective To determine whether the Nefertiti lift produces a measurable improvement in jawline contour and jowl severity compared with untreated control, and to assess its effect on platysmal banding and patient‐reported outcomes. Methods This prospective, single‐center, split‐face study included 20 adult female participants with early lower face and neck aging. One side was randomized to receive onabotulinumtoxinA using the Nefertiti technique, with the contralateral side serving as control. Standardized photographs were obtained at baseline and 2‐week follow‐up. Two blinded facial plastic surgeons graded jowl contour and platysmal banding using validated scales. Patient‐reported outcomes included global esthetic improvement, willingness to pursue or recommend the procedure for jawline contouring. Results Platysmal banding improved significantly on the treated side in both evaluators ( p = 0.0309 and p = 0.0052), while no significant difference was observed for jowl or jawline contour. Although 53.3% reported improvement, only 31.3% would repeat or recommend the procedure for jawline contouring. Two participants (10%) had a transient asymmetric smile that resolved with balancing injection. Conclusion The Nefertiti lift reliably improves platysmal banding but does not provide meaningful short‐term jawline contour improvement. Level of Evidence 2.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →